News | June 06, 2022
Vivimed Labs posts Q4FY22 consolidated loss at Rs. 18.33 Cr
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
AstraZeneca also played a critical role in the global response to COVID-19.
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
To address the preventive & primary healthcare delivery gaps in India
The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Subscribe To Our Newsletter & Stay Updated
